The Crimean-Congo haemorrhagic fever outbreak in Omaheke region was declared on 28 November 2025, following laboratory confirmation of a case on 21 November.
The Democratic Republic of the Congo bore the heaviest burden, accounting for 96% of reported cases and 97% of deaths.
The continued partnership aims to strengthen research focused on developing effective therapeutic options for mpox, a viral disease that currently lacks a dedicated antiviral treatment.